Pro Medicus Limited (ASX:PME) Reports 42.7% Profit Increase
Pro Medicus Limited (ASX:PME) reports a 42.7% increase in after-tax profit and announces a fully franked interim dividend.
Category: Healthcare
Nuchev Limited (ASX:NUC) Appoints Nathan Cheong as CEO
Nuchev Limited (ASX:NUC) appoints Nathan Cheong as CEO, while Mick Myers transitions to COO and CFO roles.
Artrya Limited (ASX:AYA) Secures Multi-Year Contract with Sonic Healthcare Australia
Artrya Limited (ASX:AYA) secures a three-year agreement with Sonic Healthcare Australia to implement its Salix® platform for coronary artery disease assessment.
Echo IQ (ASX:EIQ) Receives $1.26M R&D Tax Incentive
Echo IQ (ASX:EIQ) secures $1.26 million R&D Tax Incentive for AI-driven cardiac technology development.
Osteopore Limited (ASX:OSX) Announces Convertible Notes Offering
Osteopore Limited (ASX:OSX) announces a $20 million convertible notes offering to fund business expansion and future projects.
Artrya Limited (ASX:AYA) Halts Trading Pending Major Announcement
Artrya Limited (ASX:AYA) suspends trading ahead of a major software license and capital raising announcement.
Wellnex Life Limited (ASX:WNX) Places Shares in Trading Halt Pending Capital Raising
Wellnex Life Limited (ASX:WNX) has initiated a trading halt pending a material capital raising announcement related to its UK LSE AIM listing.
Vitura Health Limited (ASX:VIT) Acquires Candor Medical
Vitura Health Limited (ASX:VIT) acquires Candor Medical, enhancing its specialty healthcare services and boosting EBITDA.
EMVision Medical Devices (ASX:EMV) Secures US Ethics Approval for Pivotal Trial
EMVision Medical Devices (ASX:EMV) receives US IRB approval for pivotal trial of the emu™ brain scanner, maintaining progress towards March 2025 activation.
Clarity Pharmaceuticals (ASX:CU6) Enhances Breast Cancer Pipeline with Cu-SAR-trastuzumab
Clarity Pharmaceuticals (ASX:CU6) enhances its breast cancer pipeline with new radiopharmaceutical and secures critical supply agreement.